Treatment for Chemotherapy-Related Cognitive Dysfunction: Review of The Literature von Meyers, O.I

Volltext

The Impact of DSM-5 on the Development of Drugs to Treat Major Depressive Disorder von Meyers, O.I

Volltext

The Impact of DSM-5 on the Development of Drugs to Treat Attention-Deficit/Hyperactivity Disorder von Meyers, O.I

Volltext

The Impact of DSM-5 on the Development of Drugs to Treat Schizophrenia von Meyers, O.I

Volltext

Clinical Outcome Assessments in FDA Oncology Labels Since 2010 von Meyers, O.I, Foley, K

Volltext

PCN3 - Treatment for Chemotherapy-Related Cognitive Dysfunction: Review of The Literature von Meyers, O.I.

Volltext

PRM213 - The Role of DSM in the EMA and FDA Authorization Process for Psychiatric Drugs von Meyers, O.I.

Volltext

PRM182 - The Impact of DSM-5 on the Development of Drugs to Treat Autism Spectrum Disorder von Meyers, O.I.

Volltext

PRM184 - The Impact of DSM-5 on the Development of Drugs to Treat Attention-Deficit/Hyperactivity Disorder von Meyers, O.I.

Volltext

Development And Content Validity Of An Endometriosis Pain Daily Diary von van Nooten, F.E, Paty, J.A, Elash, C.A, Turner-Bowker, D.M, Meyers, O.I, Holtkamp, G.M, Wilken, S, Boerrigter, P, Holmstrom, S

Volltext

PCN160 - Clinical Outcome Assessments in FDA Oncology Labels Since 2010 von Meyers, O.I., Foley, K.

Volltext

PIH39 - Development And Content Validity Of An Endometriosis Pain Daily Diary von van Nooten, F.E., Paty, J.A., Elash, C.A., Turner-Bowker, D.M., Meyers, O.I., Holtkamp, G.M., Wilken, S., Boerrigter, P., Holmstrom, S.

Volltext